Interleukin-1 gene cluster and IL-1 receptor polymorphisms in Iranian patients with systemic lupus erythematosus
Z Tahmasebi, M Akbarian, S Mirkazemi… - Rheumatology …, 2013 - Springer
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease of unknown etiology
with a complex pathogenesis involving multiple genetic and environmental contributions …
with a complex pathogenesis involving multiple genetic and environmental contributions …
STAT4 confers risk for rheumatoid arthritis and systemic lupus erythematosus in Mexican patients
OB Ramírez, JFM Rincón, REB Cobos, IA Ávila… - Immunology …, 2016 - Elsevier
STAT4 has been consistently associated with several autoimmune diseases, including
rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The aim of this study was …
rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The aim of this study was …
Systemic lupus erythematosus immune complexes increase the expression of SLAM family members CD319 (CRACC) and CD229 (LY-9) on plasmacytoid dendritic …
N Hagberg, J Theorell, H Schlums… - The Journal of …, 2013 - journals.aai.org
Patients with systemic lupus erythematosus (SLE) display an activated type I IFN system due
to unceasing IFN-α release from plasmacytoid dendritic cells (pDCs) stimulated by nucleic …
to unceasing IFN-α release from plasmacytoid dendritic cells (pDCs) stimulated by nucleic …
[HTML][HTML] Immune-regulatory mechanisms in systemic autoimmune and rheumatic diseases
Y Takakubo, YT Konttinen - Journal of Immunology Research, 2012 - hindawi.com
Systemic autoimmune and rheumatic diseases (SAIRDs) are thought to develop due to the
failure of autoimmune regulation and tolerance. Current therapies, such as biologics, have …
failure of autoimmune regulation and tolerance. Current therapies, such as biologics, have …
Cryptotanshinone ameliorates the pathogenesis of systemic lupus erythematosus by blocking T cell proliferation
Y Du, L Du, Z He, J Zhou, C Wen, Y Zhang - International …, 2019 - Elsevier
Systemic lupus erythematosus (SLE) is a chronic, devastating autoimmune disorder
associated with severe organ damage. Recently, the role of Signal Transducer and Activator …
associated with severe organ damage. Recently, the role of Signal Transducer and Activator …
Cytokines in systemic lupus erythematosus: their role in pathogenesis of disease and possible therapeutic opportunities
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that may involve
several organs. The disease is characterized by a recurring pattern of remission and flare …
several organs. The disease is characterized by a recurring pattern of remission and flare …
[PDF][PDF] Nigella sativa L. as immunomodulator and preventive effect on renal tissue damage of lupus mice induced by pristane
Introduction Nigella sativa L. is an herbal plant with Thimoquinone as the main therapeutic
properties. This plants has been shown to cure for various diseases and affected the …
properties. This plants has been shown to cure for various diseases and affected the …
[PDF][PDF] TNF-α messenger ribonucleic acid (mRNA) in patients with nonalcoholic steatohepatitis
Background and aim: tumor necrosis factor (TNF)-plays a significant role in the
pathogenesis of nonalcoholic steatohepatitis (NASH). A few studies have confirmed high …
pathogenesis of nonalcoholic steatohepatitis (NASH). A few studies have confirmed high …
[HTML][HTML] PPP2R2B hypermethylation causes acquired apoptosis deficiency in systemic autoimmune diseases
IK Madera-Salcedo, BE Sánchez-Hernández… - JCI insight, 2019 - ncbi.nlm.nih.gov
Chronic inflammation causes target organ damage in patients with systemic autoimmune
diseases. The factors that allow this protracted response are poorly understood. We …
diseases. The factors that allow this protracted response are poorly understood. We …
The importance of assessing medication exposure to the definition of refractory disease in systemic lupus erythematosus
L Arnaud, N Zahr, N Costedoat-Chalumeau… - Autoimmunity …, 2011 - Elsevier
Treatment of patients with Systemic Lupus Erythematosus (SLE) who have active disease
refractory to current therapeutic strategies continues to be a real challenge. Here, we …
refractory to current therapeutic strategies continues to be a real challenge. Here, we …